N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide mesylate
98%
- Product Code: 214781
CAS:
2134096-06-1
| Molecular Weight: | 621.757 g./mol | Molecular Formula: | C₃₁H₃₉N₇O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in research as a potent and selective inhibitor of the epidermal growth factor receptor (EGFR), particularly effective against mutant forms associated with non-small cell lung cancer (NSCLC). Shows high activity against EGFR T790M and C797S mutations, which are linked to resistance to earlier generations of EGFR inhibitors. Enables the study of signaling pathways in cancer cells and supports the development of next-generation targeted therapies. Due to its ability to cross the blood-brain barrier, it is also investigated for treating brain metastases of lung cancer. Primarily utilized in preclinical studies for evaluating antitumor efficacy and pharmacokinetic profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | $658.67 |
+
-
|
| 10mg | 10-20 days | $1,053.86 |
+
-
|
| 25mg | 10-20 days | $1,844.26 |
+
-
|
N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide mesylate
Used in research as a potent and selective inhibitor of the epidermal growth factor receptor (EGFR), particularly effective against mutant forms associated with non-small cell lung cancer (NSCLC). Shows high activity against EGFR T790M and C797S mutations, which are linked to resistance to earlier generations of EGFR inhibitors. Enables the study of signaling pathways in cancer cells and supports the development of next-generation targeted therapies. Due to its ability to cross the blood-brain barrier, it is also investigated for treating brain metastases of lung cancer. Primarily utilized in preclinical studies for evaluating antitumor efficacy and pharmacokinetic profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :